Inuvo (INUV) corrects 30,702-unit RSU grant date for director

Rhea-AI Filing Summary

Inuvo, Inc. (INUV) reports an amended insider transaction for a director. The reporting person, a director of Inuvo, received a grant of 30,702 Restricted Stock Units on July 1, 2026, recorded as a derivative security with no cash exercise price.

Each restricted stock unit represents a contingent right to receive one share of Inuvo common stock, for a total of 30,702 underlying shares, with both the exercise and expiration date shown as January 1, 2027. The amendment corrects the exercisable date disclosure from July 1, 2027 to January 1, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Howe Richard K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1	30,702	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 30,702 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock.

Key Figures

RSUs Granted: 30,702 units Price per RSU: $0.0000 per unit RSUs Held After Transaction: 30,702 units +2 more

5 metrics

RSUs Granted 30,702 units Restricted Stock Units granted to a director on July 1, 2026

Price per RSU $0.0000 per unit Reported transaction price per Restricted Stock Unit

RSUs Held After Transaction 30,702 units Total derivative securities following the RSU grant

Exercise Date January 1, 2027 Exercise date for the reported Restricted Stock Units

Expiration Date January 1, 2027 Expiration date for the reported Restricted Stock Units

Key Terms

Restricted Stock Unit, derivative security, contingent right

3 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

derivative security financial

"The RSUs are reported as a derivative security with no cash exercise price"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

contingent right financial

"represents a contingent right to receive one share of Issuer's Common Stock"

FAQ

What insider transaction did Inuvo, Inc. (INUV) report in this amended Form 4?

Inuvo, Inc. reported that a director received a grant of 30,702 Restricted Stock Units on July 1, 2026. These RSUs are derivative securities representing rights to future Inuvo common shares, rather than a cash purchase or sale in the market.

Why was this Form 4 for INUV filed as an amendment (Form 4/A)?

The Form 4 was amended to correct the exercisable date of the restricted stock units. The date was revised from July 1, 2027 to January 1, 2027, clarifying when the RSUs become exercisable into common shares.

How many Inuvo (INUV) shares are underlying the director’s RSU grant?

The director’s award covers 30,702 Restricted Stock Units, each representing a contingent right to receive one share of Inuvo common stock. In total, the grant relates to 30,702 underlying shares if all units settle in stock.

What was the reported price per share for the INUV Restricted Stock Unit grant?

The grant was reported with a transaction price per share of $0.0000. This reflects that RSUs are typically a form of equity compensation granted without a cash exercise price, rather than a market purchase of existing shares.

What are the key dates for the Inuvo (INUV) RSU grant to the director?

The RSU grant date is July 1, 2026, with both the exercise date and expiration date shown as January 1, 2027. The amendment specifically corrects the exercisable date to January 1, 2027 for these units.

How many derivative securities does the Inuvo director hold after this RSU transaction?

Following the reported grant, the director’s holdings in this derivative security are 30,702 Restricted Stock Units. Each RSU corresponds to one share of Inuvo common stock, contingent on the terms of the award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/19/2026 - 04:04 PM Accepted by SEC EDGAR 08/19/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Howe Richard K

(Last) (First) (Middle)

500 PRESIDENT CLINTON AVE.

SUITE 300

(Street)

LITTLE ROCK ARKANSAS 72201

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inuvo, Inc. [ INUV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/06/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	07/01/2026		A		30,702		01/01/2027	01/01/2027	Common Stock	30,702	$0.0000	30,702	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock.

Remarks:

This Form 4 is being amended to correct the exercisable date of the restricted stock units from 7/1/27 to 1/1/27.

	/s/ Richard K. Howe	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)